International Clinical Outcome Study for Dysferlinopathy (LGMD2B/Miyoshi)

An opportunity for patients with dysferlinopathies to participate in a clinical research study. This study is essential for finding outcomes that can be measured during clinical trials. Without good clinical outcomes, effective clinical trials cannot be performed.

The study started recruiting on September 1, 2012 and will continue until August 31, 2013 at 14 centers worldwide.  Please click here for a list of locations and the recruitment status of each site.  If you would like more information regarding the study please email us at contact@dysferlinoutcomestudy.org or fill out the contact form below.

The Jain Foundation along with Dr. Kate Bushby at Newcastle University is coordinating the study across the 14 centers. The study is funded by the Jain Foundation.  Additional details, including contact information, can be found in the "Who is running the study" question in the FAQ section.

Why participate?

The outcome measures identified in this study are needed for the development and success of future clinical trials. In addition, the information gained in this study will provide a better understanding of the disease, ensure optimal care and treatment, and will lead to new and better therapies.

Please visit the pages below for more information about the International Clinical Outcome Study:

Want to learn more or sign up? Contact us today!

If you want to learn more about the International Clinical Outcome Study or if you are interested in signing up, please contact us by emailing contact@dysferlinoutcomestudy.org or by filling out the form below.

"*" means mandatory field

We value your privacy. We will never give, lease, sell or otherwise disclose any of your personal or medical information without your consent and we will only contact you in regards to the Clinical Outcome Study.